BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37394416)

  • 1. A Nomogram for Enhancing the Diagnostic Effectiveness of Solid Breast BI-RADS 3-5 Masses to Determine Malignancy Based on Imaging Aspects of Conventional Ultrasonography and Contrast-Enhanced Ultrasound.
    Yan M; Peng C; He D; Xu D; Yang C
    Clin Breast Cancer; 2023 Oct; 23(7):693-703. PubMed ID: 37394416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses.
    Niu Q; Zhao L; Wang R; Du L; Shi Q; Jia C; Li G; Jin L; Li F
    Eur J Radiol; 2024 Apr; 173():111391. PubMed ID: 38422608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS.
    Luo WQ; Huang QX; Huang XW; Hu HT; Zeng FQ; Wang W
    Sci Rep; 2019 Aug; 9(1):11921. PubMed ID: 31417138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of diagnostic efficacy of multimode ultrasound in BI-RADS 4 breast neoplasms and establishment of a predictive model.
    Chen Y; Lu J; Li J; Liao J; Huang X; Zhang B
    Front Oncol; 2022; 12():1053280. PubMed ID: 36505867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
    Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
    Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
    Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
    Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
    Du YR; Wu Y; Chen M; Gu XG
    Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications.
    Cheng M; Tong W; Luo J; Li M; Liang J; Pan F; Pan J; Zheng Y; Xie X
    Clin Radiol; 2020 Dec; 75(12):934-941. PubMed ID: 32814625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RADS 4 lesions detected by magnetic resonance imaging.
    Guo W; Li F; Jia C; Wang T; Zhang X; Yao G; Shi X; Bai M
    Br J Radiol; 2022 Aug; 95(1136):20220025. PubMed ID: 35604699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology.
    Gong LP; Li XY; Wu YN; Dong S; Zhang S; Feng YN; Lv YE; Guo XJ; Peng YQ; Du XS; Tian JW; Sun CX; Sun LT
    J Ovarian Res; 2023 Mar; 16(1):57. PubMed ID: 36945000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating Contrast-Enhanced Ultrasound into the BI-RADS Scoring System Improves Accuracy in Breast Tumor Diagnosis: A Preliminary Study in China.
    Xiao X; Dong L; Jiang Q; Guan X; Wu H; Luo B
    Ultrasound Med Biol; 2016 Nov; 42(11):2630-2638. PubMed ID: 27544439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of contrast-enhanced malignancy imaging features in secondary grade diagnosis of BI-RADS-US type 4 breast lesions.
    Gao J; Han W; Ai Si Mu Tu La DLMT; Hou X; Li ZM; Song T
    Tumori; 2021 Oct; 107(5):424-431. PubMed ID: 33124515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal Ultrasound Imaging in Breast Imaging-Reporting and Data System 4 Breast Lesions: A Prediction Model for Malignancy.
    Li XL; Lu F; Zhu AQ; Du D; Zhang YF; Guo LH; Sun LP; Xu HX
    Ultrasound Med Biol; 2020 Dec; 46(12):3188-3199. PubMed ID: 32896449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI.
    Pan J; Tong W; Luo J; Liang J; Pan F; Zheng Y; Xie X
    Br J Radiol; 2020 Aug; 93(1112):20200195. PubMed ID: 32463295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of contrast-enhanced ultrasound in breast lesions of BI-RADS 4].
    Liang YC; Jia CM; Xue Y; Lü Q; Chen F; Wang JJ
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1498-1502. PubMed ID: 29804418
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter.
    Yu MQ; Zhang LL; Jiang LP; Zhou AY
    Clin Hemorheol Microcirc; 2023; 83(3):195-205. PubMed ID: 35599475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining primary tumor features derived from conventional and contrast-enhanced ultrasound facilitates the prediction of positive axillary lymph nodes in Breast Imaging Reporting and Data System category 4 malignant breast lesions.
    Du Y; Yi CB; Du LW; Gong HY; Ling LJ; Ye XH; Zong M; Li CY
    Diagn Interv Radiol; 2023 May; 29(3):469-477. PubMed ID: 36994900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic Breast Volume Scanner and B-Ultrasound-Based Radiomics Nomogram for Clinician Management of BI-RADS 4A Lesions.
    Ma Q; Wang J; Xu D; Zhu C; Qin J; Wu Y; Gao Y; Zhang C
    Acad Radiol; 2023 Aug; 30(8):1628-1637. PubMed ID: 36456445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of contrast-enhanced ultrasonography in breast ductal abnormalities.
    Wang B; Yang D; Zhang X; Gong X; Xu T; Han J; Ren Y; Zou S; Li L; Wang Y
    Cancer Imaging; 2023 Mar; 23(1):25. PubMed ID: 36899406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.
    Xu Z; Lin Y; Huo J; Gao Y; Lu J; Liang Y; Li L; Jiang Z; Du L; Lang T; Wen G; Li Y
    Eur Radiol; 2024 Apr; 34(4):2608-2618. PubMed ID: 37840099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.